JAMA Ophthalmology

Papers
(The H4-Index of JAMA Ophthalmology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China848
Progression of Myopia in School-Aged Children After COVID-19 Home Confinement258
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration106
Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi100
Characterization of Drusen and Hyperreflective Foci as Biomarkers for Disease Progression in Age-Related Macular Degeneration Using Artificial Intelligence in Optical Coherence Tomography99
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia98
Performance of an Artificial Intelligence Chatbot in Ophthalmic Knowledge Assessment91
Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy91
Assessment of a Segmentation-Free Deep Learning Algorithm for Diagnosing Glaucoma From Optical Coherence Tomography Scans89
Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children87
Characterization of Retinal Microvascular and Choroidal Structural Changes in Parkinson Disease82
Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses82
Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy82
Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States From 2009 to 201881
A Global Assessment of Eye Health and Quality of Life77
Associations of Variation in Retinal Thickness With Visual Acuity and Anatomic Outcomes in Eyes With Neovascular Age-Related Macular Degeneration Lesions Treated With Anti–Vascular Endothelial Growth 75
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy73
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration69
Association of Age at Myopia Onset With Risk of High Myopia in Adulthood in a 12-Year Follow-up of a Chinese Cohort68
Association of Metformin Use With Age-Related Macular Degeneration67
Rates of Myopia Development in Young Chinese Schoolchildren During the Outbreak of COVID-1966
Association of Long-Duration Spaceflight With Anterior and Posterior Ocular Structure Changes in Astronauts and Their Recovery65
Progression of Photoreceptor Degeneration in Geographic Atrophy Secondary to Age-related Macular Degeneration59
Presence of SARS-CoV-2 RNA in the Cornea of Viremic Patients With COVID-1958
Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration58
Prevalence of Visual Acuity Loss or Blindness in the US56
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration56
Incidence and Progression of Myopia in Early Adulthood56
Association of Daily Wear of Eyeglasses With Susceptibility to Coronavirus Disease 2019 Infection56
Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma55
Association Between Sex Composition and Publication Productivity of Journal Editorial and Professional Society Board Members in Ophthalmology55
Prevalence of Age-Related Macular Degeneration in the US in 201953
Screening Candidates for Refractive Surgery With Corneal Tomographic–Based Deep Learning50
Retinal Displacement Following Pneumatic Retinopexy vs Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment50
Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration50
Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes50
Quantification of Fluid Resolution and Visual Acuity Gain in Patients With Diabetic Macular Edema Using Deep Learning49
SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy49
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity48
Ocular Manifestations and Clinical Characteristics of Children With Laboratory-Confirmed COVID-19 in Wuhan, China47
Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-245
Low-Shot Deep Learning of Diabetic Retinopathy With Potential Applications to Address Artificial Intelligence Bias in Retinal Diagnostics and Rare Ophthalmic Diseases44
Continued Increase of Axial Length and Its Risk Factors in Adults With High Myopia43
Outcomes of Limbal Stem Cell Transplant43
0.037259101867676